Published in J Virol on August 01, 1996
Rabbit haemorrhagic disease (RHD) and rabbit haemorrhagic disease virus (RHDV): a review. Vet Res (2012) 1.71
The evolution of poxvirus vaccines. Viruses (2015) 1.02
The current status and future directions of myxoma virus, a master in immune evasion. Vet Res (2011) 0.90
Horizontal transmissible protection against myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus. J Virol (2000) 0.88
Immunization with potato plants expressing VP60 protein protects against rabbit hemorrhagic disease virus. J Virol (1999) 0.87
Codon optimization of the rabbit hemorrhagic disease virus (RHDV) capsid gene leads to increased gene expression in Spodoptera frugiperda 9 (Sf9) cells. J Vet Sci (2013) 0.85
Symbiont survival and host-symbiont disequilibria under differential vertical transmission. Genetics (2000) 0.80
Conformational and thermal stability improvements for the large-scale production of yeast-derived rabbit hemorrhagic disease virus-like particles as multipurpose vaccine. PLoS One (2013) 0.76
In vitro permissivity of bovine cells for wild-type and vaccinal myxoma virus strains. Virol J (2007) 0.76
Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol Cell Biol (1985) 13.99
Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proc Natl Acad Sci U S A (1982) 7.04
Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters. Proc Natl Acad Sci U S A (1983) 4.69
Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature (1985) 3.62
Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature (1984) 3.32
Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature (1984) 3.03
Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc Natl Acad Sci U S A (1984) 2.85
Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine. Nature (1992) 2.67
Rabbit hemorrhagic disease virus--molecular cloning and nucleotide sequencing of a calicivirus genome. Virology (1991) 2.64
Identification and characterization of the virus causing rabbit hemorrhagic disease. J Virol (1990) 1.64
Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor. J Virol (1992) 1.59
Purification and characterization of a calicivirus as the causative agent of a lethal hemorrhagic disease in rabbits. J Virol (1990) 1.52
Oral vaccination of the fox against rabies using a live recombinant vaccinia virus. Nature (1986) 1.45
Recombinant rabbit hemorrhagic disease virus capsid protein expressed in baculovirus self-assembles into viruslike particles and induces protection. J Virol (1994) 1.43
Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein. Proc Natl Acad Sci U S A (1988) 1.43
Mapping and sequencing of a gene from myxoma virus that is related to those encoding epidermal growth factor and transforming growth factor alpha. J Virol (1987) 1.16
A vaccinia virus double recombinant expressing the F and H genes of rinderpest virus protects cattle against rinderpest and causes no pock lesions. Proc Natl Acad Sci U S A (1991) 1.06
Clinical and pathological features of viral haemorrhagic disease of rabbits and the European brown hare syndrome. Rev Sci Tech (1991) 1.05
Myxoma virus M11L ORF encodes a protein for which cell surface localization is critical in manifestation of viral virulence. Virology (1992) 1.04
Cloning and molecular characterization of the myxoma virus genome. Virology (1989) 0.98
Molecular cloning, sequencing and expression in Escherichia coli of the capsid protein gene from rabbit haemorrhagic disease virus (Spanish isolate AST/89). J Gen Virol (1994) 0.97
Enzyme-linked immunosorbent assay of antibodies to rabbit haemorrhagic disease virus and determination of its major structural proteins. J Gen Virol (1990) 0.95
Single capripoxvirus recombinant vaccine for the protection of cattle against rinderpest and lumpy skin disease. Vaccine (1993) 0.94
Viral haemorrhagic disease of rabbits: vaccination and immune response. Rev Sci Tech (1991) 0.91
Sequence and genomic organization of a rabbit hemorrhagic disease virus isolated from a wild rabbit. Virus Genes (1995) 0.90
Protection of goats against peste des petits ruminants with a vaccinia virus double recombinant expressing the F and H genes of rinderpest virus. Vaccine (1993) 0.90
The myxoma virus thymidine kinase gene: sequence and transcriptional mapping. J Gen Virol (1992) 0.81
Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature (1992) 3.89
Role of tir and intimin in the virulence of rabbit enteropathogenic Escherichia coli serotype O103:H2. Infect Immun (2000) 2.09
Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study. Ann Oncol (2005) 1.95
Identification of a clone of Escherichia coli O103:H2 as a potential agent of hemolytic-uremic syndrome in France. J Clin Microbiol (1993) 1.94
Arterial alterations with aging and high blood pressure. A noninvasive study of carotid and femoral arteries. Arterioscler Thromb (1993) 1.82
Association between local pulse pressure, mean blood pressure, and large-artery remodeling. Circulation (1999) 1.80
Genome organization of porcine epidemic diarrhoea virus. Adv Exp Med Biol (1993) 1.78
Heterologous expression of G-protein-coupled receptors: comparison of expression systems from the standpoint of large-scale production and purification. Cell Mol Life Sci (2003) 1.76
Antigenic structure of transmissible gastroenteritis virus. I. Properties of monoclonal antibodies directed against virion proteins. J Gen Virol (1986) 1.71
Complete sequence (20 kilobases) of the polyprotein-encoding gene 1 of transmissible gastroenteritis virus. Virology (1995) 1.70
Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia. Mol Psychiatry (2010) 1.69
TGEV corona virus ORF4 encodes a membrane protein that is incorporated into virions. Virology (1992) 1.69
Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ (2001) 1.69
Further characterization of aminopeptidase-N as a receptor for coronaviruses. Adv Exp Med Biol (1993) 1.67
Arterial stiffness is associated with left atrial size in hypertensive patients. Arch Cardiovasc Dis (2008) 1.58
Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo. Mol Endocrinol (1997) 1.53
Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease. Kidney Int (2006) 1.53
Biotypes and O serogroups of Escherichia coli involved in intestinal infections of weaned rabbits: clues to diagnosis of pathogenic strains. J Clin Microbiol (1989) 1.45
The predicted primary structure of the peplomer protein E2 of the porcine coronavirus transmissible gastroenteritis virus. J Gen Virol (1987) 1.45
Recombinant rabbit hemorrhagic disease virus capsid protein expressed in baculovirus self-assembles into viruslike particles and induces protection. J Virol (1994) 1.43
Differential effects of plant sterols on water permeability and on acyl chain ordering of soybean phosphatidylcholine bilayers. Proc Natl Acad Sci U S A (1991) 1.39
Sympathetic activation decreases medium-sized arterial compliance in humans. Am J Physiol (1994) 1.35
Single amino acid changes in the viral glycoprotein M affect induction of alpha interferon by the coronavirus transmissible gastroenteritis virus. J Virol (1992) 1.32
Sequence analysis of the porcine epidemic diarrhea virus genome between the nucleocapsid and spike protein genes reveals a polymorphic ORF. Virology (1994) 1.31
Cholesterol orientation and dynamics in dimyristoylphosphatidylcholine bilayers: a solid state deuterium NMR analysis. Biophys J (1999) 1.30
Four nucleotides are the minimal requirement for RNA recognition by rotavirus non-structural protein NSP3. EMBO J (1994) 1.29
Pulsatile diameter and elastic modulus of the aortic arch in essential hypertension: a noninvasive study. J Am Coll Cardiol (1989) 1.26
Marek's disease virus (MDV) homologues of herpes simplex virus type 1 UL49 (VP22) and UL48 (VP16) genes: high-level expression and characterization of MDV-1 VP22 and VP16. J Gen Virol (2000) 1.25
Determinants essential for the transmissible gastroenteritis virus-receptor interaction reside within a domain of aminopeptidase-N that is distinct from the enzymatic site. J Virol (1994) 1.25
Central pulse pressure is a major determinant of ascending aorta dilation in Marfan syndrome. Circulation (1999) 1.25
A novel polyomavirus (goose hemorrhagic polyomavirus) is the agent of hemorrhagic nephritis enteritis of geese. J Virol (2000) 1.24
Antigenic structure of transmissible gastroenteritis virus. II. Domains in the peplomer glycoprotein. J Gen Virol (1986) 1.24
Deltakephalin, Tyr-D-Thr-Gly-Phe-Leu-Thr: a new highly potent and fully specific agonist for opiate delta-receptors. Biochem Biophys Res Commun (1983) 1.23
Usefulness of omp1 restriction mapping for avian Chlamydia psittaci isolate differentiation. Res Microbiol (1995) 1.19
Remodeling of the radial artery in response to a chronic increase in shear stress. Hypertension (1996) 1.17
Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment. Circulation (2000) 1.16
Sequence and N-terminal processing of the transmembrane protein E1 of the coronavirus transmissible gastroenteritis virus. J Gen Virol (1987) 1.16
Four major antigenic sites of the coronavirus transmissible gastroenteritis virus are located on the amino-terminal half of spike glycoprotein S. J Gen Virol (1990) 1.15
Phylogenetic analysis of rabbit haemorrhagic disease virus in France between 1993 and 2000, and the characterisation of RHDV antigenic variants. Arch Virol (2003) 1.14
Recombinant G protein-coupled receptors from expression to renaturation: a challenge towards structure. Cell Mol Life Sci (2006) 1.14
Growth and growth hormone therapy in hypochondroplasia. Acta Paediatr Scand (1990) 1.13
Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases. Br J Cancer (2012) 1.13
Opposing effects of ageing on distal and proximal large arteries in hypertensives. J Hypertens Suppl (1992) 1.12
Arterial distensibility and left ventricular hypertrophy in patients with sustained essential hypertension. Am Heart J (1991) 1.12
Apoptosis in SIV infection. Cell Death Differ (2005) 1.12
Characterization of a myxoma virus-encoded serpin-like protein with activity against interleukin-1 beta-converting enzyme. J Virol (1996) 1.10
Bivalent binding of a neutralising antibody to a calicivirus involves the torsional flexibility of the antibody hinge. J Mol Biol (1997) 1.10
Central blood pressure in the management of hypertension: soon reaching the goal? J Hum Hypertens (2013) 1.09
Necrotoxic Escherichia coli (NTEC): two emerging categories of human and animal pathogens. Vet Res (1999) 1.09
Enteric coronavirus TGEV: partial sequence of the genomic RNA, its organization and expression. Biochimie (1988) 1.08
Detection of adenovirus in the waters of the Seine River estuary by nested-PCR. Mol Cell Probes (1998) 1.08
Caspase-dependent and -independent T-cell death pathways in pathogenic simian immunodeficiency virus infection: relationship to disease progression. Cell Death Differ (2003) 1.08
Type III secretion-dependent cell cycle block caused in HeLa cells by enteropathogenic Escherichia coli O103. Infect Immun (2001) 1.07
Fibronectin expression and aortic wall elastic modulus in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol (1998) 1.07
Compressibility of the carotid artery in patients with pseudoxanthoma elasticum. Hypertension (2001) 1.06
Enteropathogenic Escherichia coli O103 from rabbit elicits actin stress fibers and focal adhesions in HeLa epithelial cells, cytopathic effects that are linked to an analog of the locus of enterocyte effacement. Infect Immun (1997) 1.05
Relationships between proteasomes and RNA. Mol Biol Rep (1995) 1.05
Autism spectrum disorders associated with X chromosome markers in French-Canadian males. Mol Psychiatry (2006) 1.04
Role of Adhesive Factor/Rabbit 2 in experimental enteropathogenic Escherichia coli O103 diarrhea of weaned rabbit. Vet Microbiol (1996) 1.03
Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer. Ann Oncol (2007) 1.02
Serp2, an inhibitor of the interleukin-1beta-converting enzyme, is critical in the pathobiology of myxoma virus. J Virol (1998) 1.02
Primary cerebral fibrosarcoma in a child. Clin Neuropathol (2008) 1.02
Community assessment in a vertically integrated health care system. Am J Public Health (2001) 1.02
Specific gene expression signature associated with development of autoimmune type-I diabetes using whole-blood microarray analysis. Genes Immun (2010) 1.01
In vivo/in vitro comparison of rat abdominal aorta wall viscosity. Influence of endothelial function. Arterioscler Thromb Vasc Biol (1997) 1.01
Adhesive factor/rabbit 2, a new fimbrial adhesin and a virulence factor from Escherichia coli O103, a serogroup enteropathogenic for rabbits. Infect Immun (1997) 1.01
Carotid arterial haemodynamics after mild degrees of lower-body negative pressure in man. Clin Sci (Lond) (1992) 1.01
CD4+ CCR5+ T-cell dynamics during simian immunodeficiency virus infection of Chinese rhesus macaques. J Virol (2007) 1.00
Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension. Circulation (1988) 1.00
Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging. Int J Pharm (2013) 1.00
Inhibition of ureagenesis by valproate in rat hepatocytes. Role of N-acetylglutamate and acetyl-CoA. Biochem J (1983) 0.99
Large artery stiffness in hypertension. J Hypertens Suppl (1997) 0.99
Intrinsic stiffness of the carotid arterial wall material in essential hypertensives. Hypertension (2000) 0.99
Occurrence and phenotypic characterization of Yersinia ruckeri strains with biofilm-forming capacity in a rainbow trout farm. Appl Environ Microbiol (2002) 0.98
[Incidence of constipation after recent vascular hemiplegia: a prospective cohort of 152 patients]. Rev Neurol (Paris) (2002) 0.97
Hepatitis of viral origin in Leporidae: introduction and aetiological hypotheses. Rev Sci Tech (1991) 0.97
The long-term cytoskeletal rearrangement induced by rabbit enteropathogenic Escherichia coli is Esp dependent but intimin independent. Mol Microbiol (1999) 0.97
Hemoprotozoa of domestic animals in France: prevalence and molecular characterization. Vet Parasitol (2008) 0.96
The experimental production of diarrhoea in colostrum deprived axenic and gnotoxenic calves with enteropathogenic Escherichia coli, rotavirus, coronavirus and in a combined infection of rotavirus and E. coli. Ann Rech Vet (1978) 0.96
Incremental conductance levels of GABAA receptors in dopaminergic neurones of the rat substantia nigra pars compacta. J Physiol (1999) 0.96
Temporal and spatial changes in cell wall composition in developing grains of wheat cv. Hereward. Planta (2010) 0.96
Intrachromosomal recombination mediated by papovavirus large T antigens. J Virol (1990) 0.96
Morphogenesis of a highly replicative EGFPVP22 recombinant Marek's disease virus in cell culture. J Virol (2007) 0.96
Incompressibility of the human arterial wall: an in vitro ultrasound study. J Hypertens Suppl (1992) 0.95
Molecular biology of transmissible gastroenteritis virus. Vet Microbiol (1990) 0.95
msABC: a modification of Hudson's ms to facilitate multi-locus ABC analysis. Mol Ecol Resour (2010) 0.95